Abdulla A. Damluji, MD, PhD, MBA
@drdamluji.bsky.social
•Mesopotamian
•Former competitive swimmer
•Interventional cardiologist: #Aging
•Dean’s Scholar, Finance @NYUStern
•Every heart vibrates to that iron string!
•Former competitive swimmer
•Interventional cardiologist: #Aging
•Dean’s Scholar, Finance @NYUStern
•Every heart vibrates to that iron string!
Invasive Strategies in Older Adults Undergoing Revascularization for NSTEMI and STEMI: Insights from Two Recent Meta-Analyses
Short summary is here.
👇👇👇
www.linkedin.com/pulse/invasi...
Short summary is here.
👇👇👇
www.linkedin.com/pulse/invasi...
Invasive Strategies in Older Adults Undergoing Revascularization for NSTEMI and STEMI: Insights from Two Recent Meta-Analyses
Introduction Older adults with acute coronary syndromes (ACS) are often excluded from clinical trials, leaving significant gaps in evidence-based care for this growing population. Two recent meta-anal...
www.linkedin.com
December 8, 2024 at 2:02 PM
Invasive Strategies in Older Adults Undergoing Revascularization for NSTEMI and STEMI: Insights from Two Recent Meta-Analyses
Short summary is here.
👇👇👇
www.linkedin.com/pulse/invasi...
Short summary is here.
👇👇👇
www.linkedin.com/pulse/invasi...
Aortic Valve Replacement vs Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis: @jaccjournals.bsky.social
🥸Early TAVR led to less unplanned CV or HF hospitalization and stroke: @PhilGenereuxMD
😱 Summary
👇👇👇
🥸Early TAVR led to less unplanned CV or HF hospitalization and stroke: @PhilGenereuxMD
😱 Summary
👇👇👇
December 8, 2024 at 1:29 PM
Aortic Valve Replacement vs Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis: @jaccjournals.bsky.social
🥸Early TAVR led to less unplanned CV or HF hospitalization and stroke: @PhilGenereuxMD
😱 Summary
👇👇👇
🥸Early TAVR led to less unplanned CV or HF hospitalization and stroke: @PhilGenereuxMD
😱 Summary
👇👇👇
🥸Two meta-analyses for older adults undergoing revascularization:
😱NSTEMI: ahajournals.org/doi/epub/10....
😱 STEMI: agsjournals.onlinelibrary.wiley.com/doi/epdf/10....
🥸We had a great journal club at American Geriatric Society with Dr Michael Nana on revacdularization in older adults
😱NSTEMI: ahajournals.org/doi/epub/10....
😱 STEMI: agsjournals.onlinelibrary.wiley.com/doi/epdf/10....
🥸We had a great journal club at American Geriatric Society with Dr Michael Nana on revacdularization in older adults
December 8, 2024 at 1:28 PM
🥸Two meta-analyses for older adults undergoing revascularization:
😱NSTEMI: ahajournals.org/doi/epub/10....
😱 STEMI: agsjournals.onlinelibrary.wiley.com/doi/epdf/10....
🥸We had a great journal club at American Geriatric Society with Dr Michael Nana on revacdularization in older adults
😱NSTEMI: ahajournals.org/doi/epub/10....
😱 STEMI: agsjournals.onlinelibrary.wiley.com/doi/epdf/10....
🥸We had a great journal club at American Geriatric Society with Dr Michael Nana on revacdularization in older adults
Long-Term Aspirin vs Clopidogrel After Coronary Stenting by Bleeding Risk and Procedural Complexity:
@jama.com cardiology
🥸Clopidogrel monotherapy in HOST-EXAM for patients with high bleeding risk or complex PCI
😱 Summary
👇👇👇
@jama.com cardiology
🥸Clopidogrel monotherapy in HOST-EXAM for patients with high bleeding risk or complex PCI
😱 Summary
👇👇👇
December 8, 2024 at 1:23 PM
Long-Term Aspirin vs Clopidogrel After Coronary Stenting by Bleeding Risk and Procedural Complexity:
@jama.com cardiology
🥸Clopidogrel monotherapy in HOST-EXAM for patients with high bleeding risk or complex PCI
😱 Summary
👇👇👇
@jama.com cardiology
🥸Clopidogrel monotherapy in HOST-EXAM for patients with high bleeding risk or complex PCI
😱 Summary
👇👇👇
🥸Listen to "Episode 18: Three studies from JACC: Cardiovascular Interventions " by Heart Corner: Innovations in Cardiovascular Science.
@jaccjournals.bsky.social
👇👇👇
spotifycreators-web.app.link/e/aC9H0tjOWOb
@jaccjournals.bsky.social
👇👇👇
spotifycreators-web.app.link/e/aC9H0tjOWOb
Episode 18: 3 studies from JACC: Cardiovascular Interventions by Heart Corner: Innovations in Cardiovascular Science
Coronary Physiological Indexes to Evaluate Myocardial Ischemia in Patients With Aortic Stenosis Undergoing Valve Replacement
Balloon-Expandable vs Self-Expanding Valves for Transcatheter Treatment of...
spotifycreators-web.app.link
November 30, 2024 at 1:56 PM
🥸Listen to "Episode 18: Three studies from JACC: Cardiovascular Interventions " by Heart Corner: Innovations in Cardiovascular Science.
@jaccjournals.bsky.social
👇👇👇
spotifycreators-web.app.link/e/aC9H0tjOWOb
@jaccjournals.bsky.social
👇👇👇
spotifycreators-web.app.link/e/aC9H0tjOWOb
Coronary Physiological Indexes to Evaluate Myocardial Ischemia in Patients With Aortic Stenosis Undergoing Valve Replacement: @jaccjournals.bsky.social
🥸 Do you rely on FFR/DFR in AS patients undergoing AVR?
😱 Does AS mask coronary physiology??
👇👇👇
🥸 Do you rely on FFR/DFR in AS patients undergoing AVR?
😱 Does AS mask coronary physiology??
👇👇👇
November 30, 2024 at 1:51 PM
Coronary Physiological Indexes to Evaluate Myocardial Ischemia in Patients With Aortic Stenosis Undergoing Valve Replacement: @jaccjournals.bsky.social
🥸 Do you rely on FFR/DFR in AS patients undergoing AVR?
😱 Does AS mask coronary physiology??
👇👇👇
🥸 Do you rely on FFR/DFR in AS patients undergoing AVR?
😱 Does AS mask coronary physiology??
👇👇👇
A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia: @CircAHA
🥸 Proteomics and use of AI is the new frontier of biomarkers
😱 Summary
👇👇👇
🥸 Proteomics and use of AI is the new frontier of biomarkers
😱 Summary
👇👇👇
November 30, 2024 at 1:45 PM
A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia: @CircAHA
🥸 Proteomics and use of AI is the new frontier of biomarkers
😱 Summary
👇👇👇
🥸 Proteomics and use of AI is the new frontier of biomarkers
😱 Summary
👇👇👇
🥸Listen to a more detailed discussion on the @jaccjournals.bsky.social
👇👇👇
"Episode 17: TTVR: The Future of Tricuspid Valve Replacement" by Heart Corner: Innovations in Cardiovascular Science."
creators.spotify.com/pod/show/abd...
👇👇👇
"Episode 17: TTVR: The Future of Tricuspid Valve Replacement" by Heart Corner: Innovations in Cardiovascular Science."
creators.spotify.com/pod/show/abd...
Episode 17: TTVR: The Future of Tricuspid Valve Replacement by Heart Corner: Innovations in Cardiovascular Science
This JACC State-of-the-Art Review article provides a comprehensive overview of transcatheter tricuspid valve replacement (TTVR) for treating severe tricuspid regurgitation. The article details current...
creators.spotify.com
November 24, 2024 at 2:53 PM
🥸Listen to a more detailed discussion on the @jaccjournals.bsky.social
👇👇👇
"Episode 17: TTVR: The Future of Tricuspid Valve Replacement" by Heart Corner: Innovations in Cardiovascular Science."
creators.spotify.com/pod/show/abd...
👇👇👇
"Episode 17: TTVR: The Future of Tricuspid Valve Replacement" by Heart Corner: Innovations in Cardiovascular Science."
creators.spotify.com/pod/show/abd...
Transcatheter Tricuspid Valve Replacement: @JACCJournals
🥸 Back from #AHA24 - a great meeting...
😱Let's summarize this for the structural community
👇👇👇
🥸 Back from #AHA24 - a great meeting...
😱Let's summarize this for the structural community
👇👇👇
November 24, 2024 at 2:49 PM
Transcatheter Tricuspid Valve Replacement: @JACCJournals
🥸 Back from #AHA24 - a great meeting...
😱Let's summarize this for the structural community
👇👇👇
🥸 Back from #AHA24 - a great meeting...
😱Let's summarize this for the structural community
👇👇👇
Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia: @NEJM
🥸 One of my friends said that #AHA24 brought a lot of enthusiasm back: @ahascience.bsky.social
😱 Catheter ablation for VT - it works: VANISH2
Summary
👇
🥸 One of my friends said that #AHA24 brought a lot of enthusiasm back: @ahascience.bsky.social
😱 Catheter ablation for VT - it works: VANISH2
Summary
👇
November 18, 2024 at 5:15 PM
Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia: @NEJM
🥸 One of my friends said that #AHA24 brought a lot of enthusiasm back: @ahascience.bsky.social
😱 Catheter ablation for VT - it works: VANISH2
Summary
👇
🥸 One of my friends said that #AHA24 brought a lot of enthusiasm back: @ahascience.bsky.social
😱 Catheter ablation for VT - it works: VANISH2
Summary
👇
Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease: @NEJM
🥸 Trials from the #AHA24 continues; bravo @ahascience.bsky.social for a very exciting meeting in Chicago!
😱 Summary
👇👇👇
🥸 Trials from the #AHA24 continues; bravo @ahascience.bsky.social for a very exciting meeting in Chicago!
😱 Summary
👇👇👇
November 18, 2024 at 4:36 PM
Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease: @NEJM
🥸 Trials from the #AHA24 continues; bravo @ahascience.bsky.social for a very exciting meeting in Chicago!
😱 Summary
👇👇👇
🥸 Trials from the #AHA24 continues; bravo @ahascience.bsky.social for a very exciting meeting in Chicago!
😱 Summary
👇👇👇
Listen to "Episode 16: Update from the American Heart Association 2024 Science Meeting from 2024" by Heart Corner: Innovations in Cardiovascular Science.
🥸Many thanks to @ahascience.bsky.social for great meeting: #AHA24
👇👇👇
creators.spotify.com/pod/show/abd...
🥸Many thanks to @ahascience.bsky.social for great meeting: #AHA24
👇👇👇
creators.spotify.com/pod/show/abd...
Episode 16: Update from the American Heart Association 2024 Science Meeting from 2024 by Heart Corner: Innovations in Cardiovascular Science
The first trial examines the effects of tirzepatide on patients with heart failure with preserved ejection fraction and obesity. The study found that tirzepatide significantly reduced the risk of deat...
creators.spotify.com
November 18, 2024 at 4:29 PM
Listen to "Episode 16: Update from the American Heart Association 2024 Science Meeting from 2024" by Heart Corner: Innovations in Cardiovascular Science.
🥸Many thanks to @ahascience.bsky.social for great meeting: #AHA24
👇👇👇
creators.spotify.com/pod/show/abd...
🥸Many thanks to @ahascience.bsky.social for great meeting: #AHA24
👇👇👇
creators.spotify.com/pod/show/abd...
Intensive Blood-Pressure Control in Patients with Type 2 Diabetes: @NEJM
🥸 Day 3 of #AHA24 continues: Great work @ahascience.bsky.social
😱 Let's summarize BPROAD trial
👇👇👇
🥸 Day 3 of #AHA24 continues: Great work @ahascience.bsky.social
😱 Let's summarize BPROAD trial
👇👇👇
November 18, 2024 at 3:53 PM
Intensive Blood-Pressure Control in Patients with Type 2 Diabetes: @NEJM
🥸 Day 3 of #AHA24 continues: Great work @ahascience.bsky.social
😱 Let's summarize BPROAD trial
👇👇👇
🥸 Day 3 of #AHA24 continues: Great work @ahascience.bsky.social
😱 Let's summarize BPROAD trial
👇👇👇